David Gearing
Nessuna posizione attualmente
Storia della carriera di David Gearing
Precedenti posizioni note di David Gearing
Società | Posizione | Inizio | Fine |
---|---|---|---|
NEXVET BIOPHARMA PUBLIC LIMITED CO | Direttore Tecnico/Scientifico/R&S | - | 10/03/2017 |
Fondatore | - | 10/03/2017 | |
CSL LIMITED | Direttore Tecnico/Scientifico/R&S | 01/01/2000 | - |
Millennium Biotherapeutics, Inc. | Fondatore | 01/01/1996 | - |
Corporate Officer/Principal | 01/01/1996 | - | |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Corporate Officer/Principal | 01/08/1994 | - |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Direttore Tecnico/Scientifico/R&S | 01/01/1990 | - |
Monash Institute of Medical Research | Corporate Officer/Principal | - | - |
The University of Queensland | Corporate Officer/Principal | - | - |
Nexvet Australia Pty Ltd.
Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Direttore Tecnico/Scientifico/R&S | 01/02/2010 | - |
Fondatore | 01/02/2010 | - |
Formazione di David Gearing
University of Leeds | Undergraduate Degree |
Monash University | Doctorate Degree |
Statistiche
Distribuzione geografica
Australia | 6 |
Stati Uniti | 4 |
Irlanda | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 4 |
Founder | 3 |
Settori
Health Technology | 5 |
Consumer Services | 4 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
CSL LIMITED | Health Technology |
Aziende private | 6 |
---|---|
Nexvet Australia Pty Ltd.
Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Health Technology |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Millennium Biotherapeutics, Inc. | |
Nexvet Biopharma Plc
Nexvet Biopharma Plc Pharmaceuticals: MajorHealth Technology Nexvet Biopharma Plc engaged in the provision of integrated biopharmaceutical business. It focused on transforming the therapeutic market for companion animals, such as dogs and cats, by developing and commercializing novel, species-specific biologics. The company was founded in September 2014 and was headquartered in Dublin, Ireland. | Health Technology |
Monash Institute of Medical Research |
- Borsa valori
- Insiders
- David Gearing
- Esperienza